Intuniv and Spirometry abnormal - a phase IV clinical study of FDA data

Summary:

We study 4,710 people who take Intuniv (guanfacine hydrochloride) or have Spirometry abnormal. No report of Spirometry abnormal is found in people who take Intuniv.

The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.

What is Intuniv?

Intuniv has active ingredients of guanfacine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 3,959 Intuniv users. Check the latest studies of Intuniv.

What is Spirometry Abnormal?

Spirometry abnormal is found to be associated with 137 drugs and 94 conditions by eHealthMe. Check the latest studies of Spirometry abnormal.

On Apr, 09, 2026

No report is found.

Do you take Intuniv and have Spirometry abnormal?

- Check whether Spirometry abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Intuniv:

Intuniv (3,959 reports)

Browse all side effects of Intuniv:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Spirometry abnormal:

Spirometry abnormal

Browse all the conditions that are associated with Spirometry abnormal:

Spirometry abnormal

How the study uses the data?

The study uses data from the FDA. It is based on guanfacine hydrochloride (the active ingredients of Intuniv) and Intuniv (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.